DON ESCARZEGA-PHAN: Open Payments
NPI 1073747150 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 40 payments from 15 companies in 2025. Trend: 2023 $842 · 2024 $942 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $275 |
| PFIZER INC. | 8 | $143 |
| Abbott Laboratories | 3 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Medtronic, Inc. | 2 | $33 |
| Averitas Pharma Inc. | 1 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
| Tonix Medicines, Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $21 |
Products named: Belbuca, NURTEC ODT, JOURNAVX, ETERNA, RELISTOR, INCEPTIV, QUTENZA, HORIZANT.
Industry payments across TX — which companies pay providers there.
